In breast cancer, overexpression of RACGAP1 was frequently linked to a high tendency of nipple invasion, lymph node/distant metastasis, and an advanced TNM stage and worse survival outcomes [32, 33]. Here, RACGAP1 is linked to breast carcinoma.